IFF's proactive R&D investments and strategic acquisitions/divestitures position it for long-term growth, especially in high-margin segments and emerging markets. Divesting the pharma segment allows IFF to focus on core businesses, improve operational efficiency, and channel resources into higher-growth, higher-margin areas. Despite recent stagnating revenue growth and risks from input costs and forex, IFF's essential product portfolio and productivity initiatives provide resilience.
Review International Flavors' (IFF) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.
IFF expects sales between $10.6 billion and $10.9 billion for fiscal 2025.
![]() IFF 2 months ago | Other | €0.35 Per Share |
![]() IFF 5 months ago | Other | €0.35 Per Share |
![]() IFF 8 months ago | Other | €0.35 Per Share |
![]() IFF 11 months ago | Other | €0.35 Per Share |
![]() IFF 21 Mar 2024 | Other | €0.35 Per Share |
4 Aug 2025 (46 Days) Date | | - Cons. EPS | - EPS |
6 May 2025 Date | | 1.14 Cons. EPS | 1.2 EPS |
5 May 2025 Date | | - Cons. EPS | - EPS |
18 Feb 2025 Date | | - Cons. EPS | - EPS |
5 Nov 2024 Date | | - Cons. EPS | - EPS |
![]() IFF 2 months ago | Other | €0.35 Per Share |
![]() IFF 5 months ago | Other | €0.35 Per Share |
![]() IFF 8 months ago | Other | €0.35 Per Share |
![]() IFF 11 months ago | Other | €0.35 Per Share |
![]() IFF 21 Mar 2024 | Other | €0.35 Per Share |
4 Aug 2025 (46 Days) Date | | - Cons. EPS | - EPS |
6 May 2025 Date | | 1.14 Cons. EPS | 1.2 EPS |
5 May 2025 Date | | - Cons. EPS | - EPS |
18 Feb 2025 Date | | - Cons. EPS | - EPS |
5 Nov 2024 Date | | - Cons. EPS | - EPS |
Chemicals - Specialty Industry | Basic Materials Sector | Mr. Jon Erik Fyrwald CEO | XSTU Exchange | US4595061015 ISIN |
US Country | 22,400 Employees | 21 Mar 2025 Last Dividend | 20 Jan 1994 Last Split | 31 Dec 1981 IPO Date |
International Flavors & Fragrances Inc., a pioneer in the development and manufacturing of a broad spectrum of ingredients and solutions, serves a global market with a focus on the cosmetic, food and beverage, and pharmaceutical sectors. Established in 1909 and based in New York, New York, the company has carved out a significant presence across the United States, Europe, and various international locations. It operates across four primary segments: Nourish, Health & Biosciences, Scent, and Pharma Solutions, catering to a diverse clientele that includes manufacturers of perfumes, cosmetics, personal care products, soaps, detergents, processed foods, beverages, dietary supplements, and pharmaceuticals, among others.
Focused on enhancing the flavor and appeal of food products, the Nourish segment offers natural and plant-based specialty ingredients, including flavor compounds for savory items, beverages, sweets, and dairy. It also provides a suite of spices, seasoning ingredients, savory solutions (spices, sauces, marinades, mixtures), and natural solutions for extending shelf life like antioxidants and anti-microbials.
This segment produces innovative enzymes, food cultures, probiotics, and specialty ingredients suited for both food and non-food applications, aiming to improve health and nutritional profile of consumer products.
The Scent segment supplies fragrance compounds for fine fragrances (perfumes, colognes), consumer fragrances, and a variety of fragrance ingredients (synthetic and natural flavor extracts, botanical extracts, distillates, essential oils, aroma chemicals, natural gums, and resins). Additionally, it delivers cosmetic active ingredients, including active and functional components and delivery systems tailored for the cosmetic and personal care industries.
Specializing in the production of cellulosic and seaweed-based pharma excipients, this segment supports the pharmaceutical industry by offering ingredients that enhance the efficacy, stability, and delivery of drug products.